{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:47:28Z","timestamp":1779148048579,"version":"3.51.4"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"\n OBJECTIVES:<\/jats:title>\n To determine long-term clinical outcome in children with confirmed Lyme neuroborreliosis (LNB) and to evaluate persistent subjective symptoms compared with a control group.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n After a median of 5 years, 84 children with confirmed LNB underwent a neurologic re-examination, including a questionnaire. Medical records were analyzed, and a control group (n = 84) was included.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n The total recovery rate was 73% (n = 61). Objective neurologic findings, defined as \u201cdefinite sequelae,\u201d were found in 16 patients (19%). The majority of these children had persistent facial nerve palsy (n = 11), but other motor or sensory deficits occurred (n = 5). Neurologic signs and\/or symptoms defined as \u201cpossible sequelae\u201d were found in another 7 patients (8%), mainly of sensory character. Nonspecific subjective symptoms were reported by 35 patients (42%) and 32 controls (38%) (nonsignificant). Affected daily activities or school performance were reported to the same extent in both groups (23% vs 20%, nonsignificant).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n The long-term clinical recovery rate was 73% in children with confirmed LNB. Persistent facial nerve palsy occurred in 13%, whereas other motor or sensory deficits were found in another 14%. Neurologic deficits did not affect daily activities or school performance more often among patients than controls and should be considered as mild. Furthermore, nonspecific subjective symptoms such as headache, fatigue, or memory or concentration problems were reported as often among patients as controls and should not be considered as sequelae after LNB.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2011-3719","type":"journal-article","created":{"date-parts":[[2012,7,17]],"date-time":"2012-07-17T13:24:54Z","timestamp":1342531494000},"page":"262-269","source":"Crossref","is-referenced-by-count":62,"title":["Long-term Clinical Outcome After Lyme Neuroborreliosis in Childhood"],"prefix":"10.1542","volume":"130","author":[{"given":"Barbro H.","family":"Skogman","sequence":"first","affiliation":[{"name":"Clinical Department of Pediatrics, Falun General Hospital, Falun, Sweden;"},{"name":"Center for Clinical Research in Dalarna, Falun, Sweden;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajsa","family":"Glim\u00e5ker","sequence":"additional","affiliation":[{"name":"Divisions of Infectious Diseases,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nordwall","sequence":"additional","affiliation":[{"name":"Clinical Department of Pediatrics, Vrinnevi General Hospital, Norrk\u00f6ping, Sweden"},{"name":"Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Vrethem","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden; and"},{"name":"Neurology and Neurophysiology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"\u00d6dkvist","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden; and"},{"name":"Otorhinolaryngology at the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Forsberg","sequence":"additional","affiliation":[{"name":"Divisions of Infectious Diseases,"},{"name":"Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"issue":"9396","key":"2021120821031110300_B1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0140-6736(03)14798-8","article-title":"Lyme borreliosis.","volume":"362","author":"Stanek","year":"2003","journal-title":"Lancet"},{"issue":"21\u201322","key":"2021120821031110300_B2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00508-006-0687-x","article-title":"Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut.","volume":"118","author":"Steere","year":"2006","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"2021120821031110300_B3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2021120821031110300_B4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00128072-200305060-00002","article-title":"Diagnosis, treatment, and prevention of Lyme disease in children.","volume":"5","author":"Eppes","year":"2003","journal-title":"Paediatr Drugs"},{"key":"2021120821031110300_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1993.tb18082.x","article-title":"Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis.","volume":"386","author":"Christen","year":"1993","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"2021120821031110300_B6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365540802593453","article-title":"Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.","volume":"41","author":"\u00d8ymar","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"2021120821031110300_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.idc.2007.12.007","article-title":"Lyme disease in children.","volume":"22","author":"Feder","year":"2008","journal-title":"Infect Dis Clin North Am"},{"issue":"11","key":"2021120821031110300_B8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/adc.2009.176529","article-title":"Clinical presentation of childhood neuroborreliosis; neurological examination may be normal.","volume":"95","author":"Broekhuijsen-van Henten","year":"2010","journal-title":"Arch Dis Child"},{"issue":"23","key":"2021120821031110300_B9","first-page":"741","article-title":"European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis.","volume":"108","author":"Stanek","year":"1996","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"2021120821031110300_B10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2021120821031110300_B11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"issue":"5","key":"2021120821031110300_B12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/00365540902787666","article-title":"Laboratory data in children with Lyme neuroborreliosis, relation to clinical presentation and duration of symptoms.","volume":"41","author":"Tveitnes","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"12","key":"2021120821031110300_B13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","article-title":"Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.","volume":"27","author":"Skogman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2021120821031110300_B14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol"},{"issue":"12","key":"2021120821031110300_B15","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/00006454-200212000-00011","article-title":"Successful treatment of neuroborreliosis with ten day regimens.","volume":"21","author":"Thorstrand","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2021120821031110300_B16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QCO.0b013e32833890e2","article-title":"Lyme borreliosis: current issues in diagnosis and management.","volume":"23","author":"O\u2019Connell","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"2021120821031110300_B17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/00365540110080421","article-title":"5-y Follow-up study of patients with neuroborreliosis.","volume":"34","author":"Berglund","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"6","key":"2021120821031110300_B18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0165-5876(03)00061-2","article-title":"Acute facial palsy in children\u2014a 2-year follow-up study with focus on Lyme neuroborreliosis.","volume":"67","author":"Skogman","year":"2003","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"2021120821031110300_B19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/00365549850160927","article-title":"Paediatric facial paralysis caused by Lyme borreliosis: a prospective and retrospective analysis.","volume":"30","author":"Peltomaa","year":"1998","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2021120821031110300_B20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.mao.0000178148.98762.00","article-title":"Long-term outcome of facial palsy in neuroborreliosis.","volume":"26","author":"Bagger-Sj\u00f6b\u00e4ck","year":"2005","journal-title":"Otol Neurotol"},{"issue":"4","key":"2021120821031110300_B21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1034\/j.1600-0404.2002.01358.x","article-title":"Chronic symptoms are common in patients with neuroborreliosis \u2014 a questionnaire follow-up study.","volume":"106","author":"Vrethem","year":"2002","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"2021120821031110300_B22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"13","key":"2021120821031110300_B23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"2021120821031110300_B24","first-page":"1190","article-title":"Cognitive effects of Lyme disease in children: a 4 year follow-up study.","volume":"26","author":"Adams","year":"1999","journal-title":"J Rheumatol"},{"issue":"2","key":"2021120821031110300_B25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.112.2.e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease.","volume":"112","author":"V\u00e1zquez","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"2021120821031110300_B26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.410300212","article-title":"Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi\u2014specific immunoglobulin G, A, and M.","volume":"30","author":"Hansen","year":"1991","journal-title":"Ann Neurol"},{"issue":"2","key":"2021120821031110300_B27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/019459988509300202","article-title":"Facial nerve grading system.","volume":"93","author":"House","year":"1985","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"11","key":"2021120821031110300_B28","first-page":"2249","article-title":"Outcomes of children treated for Lyme disease.","volume":"25","author":"Wang","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"2021120821031110300_B29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0385-8146(97)10039-6","article-title":"Lyme borreliosis\u2014an unusual cause of vertigo.","volume":"25","author":"Peltomaa","year":"1998","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"2021120821031110300_B30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s15010-011-0107-7","article-title":"Oral antibiotic treatment and long-term outcomes of Lyme facial nerve palsy.","volume":"39","author":"Kowalski","year":"2011","journal-title":"Infection"},{"issue":"6-7","key":"2021120821031110300_B31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.","volume":"37","author":"Borg","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2021120821031110300_B32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11908-011-0184-x","article-title":"Neurologic manifestations of lyme disease.","volume":"13","author":"Halperin","year":"2011","journal-title":"Curr Infect Dis Rep"},{"issue":"5","key":"2021120821031110300_B33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.283.5.609","article-title":"Long-term outcomes of persons with Lyme disease.","volume":"283","author":"Seltzer","year":"2000","journal-title":"JAMA"},{"issue":"5","key":"2021120821031110300_B34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: quality of life 30 months after treatment.","volume":"124","author":"Eikeland","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"2021120821031110300_B35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1331.2010.03229.x","article-title":"The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis\u2014the experience from one year of a university hospital\u2019s Lyme neuroborreliosis outpatients clinic.","volume":"18","author":"Djukic","year":"2011","journal-title":"Eur J Neurol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/2\/262\/1089675\/peds_2011-3719.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/2\/262\/1089675\/peds_2011-3719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:59:27Z","timestamp":1639011567000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/130\/2\/262\/29873\/Long-term-Clinical-Outcome-After-Lyme"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,8,1]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-3719","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,1]]}}}